Clinical Trial: Endocrine Disruptors, Toxic and Essential Chemical Elements and Polycystic Ovary Syndrome

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06968455) titled 'Endocrine Disruptors, Toxic and Essential Chemical Elements and Polycystic Ovary Syndrome' on May 05.

Brief Summary: Studies have shown that endocrine disruptors (EDs) and toxic and essential chemical elements affect women's reproductive health and may play a role in the development of polycystic ovary syndrome (PCOS). There is little research examining the association of EDs and toxic and essential chemical elements with PCOS, and for some chemical compounds there is none. In our study, we will examine the relationship of EDs (bisphenols, parabens, triclosan) and toxic (cadmium-Cd, lead-Pb, mercury-Hg, arsenic-As) and essential chem...